Russia’s Direct Investment Fund (RDIF), an active participant in funding the development of therapies and vaccines for that nation in […]
TrialSite has followed favipiravir with interest as this antiviral drug, originally from Japan, is approved and registered as a treatment […]
Russia’s Ministry of Health issued a temporary registration certificate announcing that Avifavir became the world’s first Favipiravir-based drug to be approved […]
The University of Oxford soon kicks “the PRINCIPLE Trial” into a higher gear now, in what they consider a pathbreaking “high-quality […]
The University of Oxford soon kicks “the PRINCIPLE Trial” into a higher gear now, in what they consider a pathbreaking “high-quality […]
Yet another nation has opted to embrace the antiviral drug Favipiravir (Avigan) as a treatment for early onset COVID-19. Approved […]
On January 6, The Lancet’s EBIoMedicine published a commentary on the use of Favipiravir for flu and COVID-19. They note […]
South African Health Products Regulatory Authority (SAHPRA) Bans Ivermectin with Criminal Liability:The South African Health Products Regulatory Authority (SAHPRA) has […]
Health Canada may be following India, Russia, some nations in Eastern Europe, and dozens of other nations who opt to […]
Glenmark Pharmaceuticals, a prominent Indian pharmaceutical firm, reports that the oral antiviral drug originating in Japan, Favipiravir, prevents the replication […]
